Pfizer Limited share price

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers therapy area and products, such as vaccines, injectables and anti-infectives, inflammation and immunology, and internal medicine for cardiovascular care, oncology, respiratory, multivitamins and multimineral, neuroscience, women's health, gastroenterology, pain management, and nutrition, addressing. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a network of independent distributors. Pfizer Limited was incorporated in 1950 and is based in Mumbai, India.Read more

Website NSE हिंदी में BSE

HealthcareDrug Manufacturers - GeneralNifty Microcap 250NSE: PFIZERISIN INE182A01018

16 Oct 2026, 3:30 PM IST₹3,814.00▲ 3.20 (0.08%)

Market Cap₹ 17,448 Cr.
Current Price₹ 3,814.00
High / Low₹ 5,446 / 3,731
Stock P/E23.7
Book Value₹ 919
Dividend Yield1.97 %
ROCE22.9 %
ROE17.20 %
Face Value₹ 10.0

More figures (10)

EPS (TTM)₹ 160.70
Price / Book4.15
OPM33.6 %
Debt / Equity0.02
Sales growth (5Y)2.4 %
Profit growth (5Y)7.7 %
Promoter holding67.0 %
EV / EBITDA15.9
Beta0.13
All-time high₹ 6,451

Price chart

Price on NSE 50 DMA 200 DMA Volume

Returns	1M	3M	6M	YTD	1Y	3Y CAGR	5Y CAGR
PFIZER	-4.99%	-18.81%	-21.51%	-23.53%	-28.33%	-1.07%	-7.06%
Nifty 50	-0.31%	-3.85%	-4.34%	-11.42%	-9.53%	+5.46%	+4.76%

Price returns only (dividends not included). Prices from NSE via Yahoo Finance; may be delayed.

Quick take

Pfizer Limited is in the Drug Manufacturers - General industry (Healthcare), with a market value of ₹17,448 crore.
It trades at 23.7 times its last 12 months' earnings and 4.2 times book value.
Revenue grew 2.4% a year over the last 5 years, profit 7.7% a year.
Return on equity was 17.2% and return on capital employed 22.9% in the latest year.
Debt was 0.02 times shareholders' equity.
The share price is 30.0% below its 52-week high and down 28.3% over one year.
Promoters and insiders hold about 67.0%; institutions about 15.5%.

Pros

Company is almost debt-free (debt is 0.02 times equity).
Healthy return on equity of 17.7% on average over the last 3 years.
Trades at 23.7 times earnings, below its 3-year median of 31.0.
Pays a healthy dividend: about 104% of profit last year.
Promoters hold a large stake of 63.92%.

Cons

Sales growth has been slow: 2.4% a year over the last 5 years.

Pros and cons are generated automatically from the reported figures. They are observations, not a recommendation to buy or sell.

AI analysis

Plenitude AI reads the figures on this page and explains them in plain language. It does not say whether to buy or sell.

About Pfizer Limited

Employees: 1,244
Head office: Mumbai
NSE industry: Healthcare

HealthcareHealthcareDrug Manufacturers - General

Part ofNifty Microcap 250

S.No.	Company	CMP ₹	P/E	Mar Cap ₹ Cr	Div Yld %	NP Qtr ₹ Cr	Qtr Profit Var %	Sales Qtr ₹ Cr	Qtr Sales Var %	ROCE %	ROE %	P/B	OPM %	Debt / Eq	Prom. Hold. %	Sales ₹ Cr	Sales Var 3Yrs %
1.	Pfizer	3,814.00	23.7	17,448	1.97	204	6.63	653	8.31	22.9	17.2	4.15	33.6	0.02	66.96	2,520	2.4
2.	GlaxoSmithKline Pharmaceuticals	2,566.10	40.7	43,471	2.26	237	-9.77	938	-3.69	55.4	49.1	19.17	32.8	0.01	75.63	3,808	5.7
3.	Rubicon Research	1,508.60	86.9	24,973	0.10	85	133.91	534	49.20	23.6	19.1	19.32	20.6	0.24	69.15	1,731	36.6
4.	Marksans Pharma	311.00	27.3	14,093	0.29	159	173.89	841	35.61	17.5	15.2	4.66	17.5	0.11	43.87	2,951	16.7
5.	Sanofi Consumer Healthcare India	3,548.70	30.7	8,185	2.10	69	13.34	236	6.70	77.0	73.1	23.49	33.9	0.06	72.52	878	27.0
6.	Senores Pharmaceuticals	1,318.40	46.4	6,072	0.00	31	55.70	180	35.95	15.5	13.4	5.61	23.0	0.37	54.93	614	159.1
7.	SMS Pharmaceuticals	450.50	40.1	4,219	0.09	21	2.04	207	5.57	13.7	14.3	5.37	15.1	0.46	74.88	887	19.3
8.	Sai Parenteral's	487.30	168.0	2,153	0.00	8	—	179	—	17.9	21.1	3.25	6.4	1.83	74.83	381	126.1
9.	CORONA Remedies	2,003.90	61.6	—	0.49	60	—	422	—	29.0	27.4	16.41	18.3	0.22	77.61	1,403	16.6
	Median: 9 Co.	1,508.60	40.7	11,139	0.29	69	13.34	422	8.31	22.9	19.1	5.61	20.6	0.22	72.52	1,403	19.3

Companies in the same industry; the median covers every company in it that we hold figures for. Tap a heading to sort. Sorting and comparing are ways to explore data, not recommendations.

Quarterly Results

Standalone figures in ₹ crore

₹ Cr	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	531	575	540	547	563	589	538	592	603	1,245	645	629	653
YOY Sales Growth %	-10.38%	-9.77%	-13.15%	-4.54%	5.93%	2.33%	-0.37%	8.28%	7.14%	111.59%	19.90%	6.31%	8.31%
	421	393	387	357	385	399	392	364	393	805	417	393	406
Material Cost %	41%	36%	34%	35%	36%	36%	37%	34%	35%	35%	35%	35%	37%
Employee Cost %	18%	16%	17%	14%	16%	17%	18%	14%	16%	15%	16%	12%	13%
Other Expenses %	21%	17%	21%	17%	17%	15%	18%	13%	14%	14%	14%	15%	13%
Operating Profit	111	183	153	189	177	189	146	228	210	440	228	236	248
OPM %	21%	32%	28%	35%	32%	32%	27%	38%	35%	35%	35%	37%	38%
	33	36	36	75	42	43	43	45	67	109	38	41	45
Exceptional items			8					173			-58	9
Interest	3	3	3	7	2	2	2	3	3	5	2	2	1
Depreciation	16	15	18	14	15	15	15	16	14	29	14	15	14
Profit before tax	126	201	176	244	203	215	172	426	260	515	192	269	277
	26%	26%	26%	27%	26%	26%	26%	22%	26%	26%	26%	26%	26%
Current tax	33	47	29	49	55	60	50	99	67	133	58	67	71
Deferred tax	-1	4	17	16	-3	-3	-5	-4	0	1	-8	2	1
	94	149	130	179	151	158	128	331	192	381	142	200	204
YOY Profit Growth %	187.34%	-52.11%	-13.73%	37.96%	61.14%	6.30%	-1.83%	85.03%	27.23%	140.46%	11.16%	-39.62%	6.63%
EPS in Rs	20.44	32.56	27.12	22.33	32.94	34.61	27.89	72.34	41.91	83.23	31.01	43.68	44.69
Raw filing

Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Latest quarter on the right.

Profit & Loss

Standalone figures in ₹ crore

₹ Cr	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	1,980	2,082	2,152	2,239	2,611	2,425	2,193	2,281	2,520	3,173
YOY Sales Growth %		5.12%	3.37%	4.04%	16.64%	-7.13%	-9.55%	4.02%	10.45%
	1,480	1,516	1,579	1,526	1,775	1,616	1,558	1,541	1,616	2,021
Material Cost %	37%	36%	37%	36%	36%	36%	36%	36%	35%	35%
Employee Cost %	16%	16%	17%	16%	15%	14%	16%	16%	15%	14%
Other Expenses %	22%	21%	20%	16%	16%	17%	19%	16%	14%	14%
Operating Profit	500	565	573	712	836	809	635	740	904	1,152
OPM %	25%	27%	27%	32%	32%	33%	29%	32%	36%	36%
	114	167	184	81	63	101	181	172	188	233
Exceptional items						33	8	173	-49	-49
Interest	0	1	11	15	10	13	15	8	9	11
Depreciation	66	71	103	109	115	106	62	61	58	72
Profit before tax	548	660	642	669	773	824	746	1,016	976	1,252
	34%	35%	21%	26%	21%	24%	26%	24%	26%	26%
Current tax	194	244	133	184	218	252	159	264	258
Deferred tax	-7	-13	0	-13	-58	-52	36	-16	-4
	360	429	509	498	613	624	551	768	722	927
YOY Profit Growth %		19.16%	18.66%	-2.26%	23.10%	1.86%	-11.64%	39.23%	-5.88%
EPS in Rs	78.70	93.78	111.28	108.77	133.89	136.38	120.51	167.79	157.92	202.61
Dividend Payout %						48%	33%	21%	104%

Compounded Sales Growth

5 Years:: 2%
3 Years:: 1%
TTM:: 37%

Compounded Profit Growth

5 Years:: 8%
3 Years:: 5%
TTM:: 15%

Stock Price CAGR

5 Years:: -7%
3 Years:: -1%
1 Year:: -28%

Return on Equity

4 Years:: 18%
Last Year:: 17%

Financial years ending March; TTM = the last four quarters. Source: the company's results filed with NSE, as reported. Tap a row marked + for its breakdown. Dividend payout = dividends paid in the year ÷ net profit.

Balance Sheet

Consolidated figures in ₹ crore, as at 31 March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	46	46	46	46
Reserves	3,162	3,550	4,172	4,157
	134	95	108	70
Short term borrowings	3	3	3	3
	659	539	585	649
Trade payables	217	166	152	216
Current liabilities	657	547	570	627
Total Liabilities	4,001	4,229	4,911	4,922
	186	152	180	157
Gross block	415	411	481	494
Accumulated depreciation	230	260	301	337
Goodwill & intangibles	572	562	552	542
CWIP	8	1	8	21
	3,807	4,077	4,723	4,744
Inventories	418	434	476	473
Trade receivables	152	188	193	182
Cash & equivalents	37	112	495	103
Current assets	2,525	2,770	3,513	3,803
Total Assets	4,001	4,229	4,911	4,922

Source: Yahoo Finance (compiled from the annual reports). Tap a row marked + for its breakdown.

Cash Flows

Consolidated figures in ₹ crore, financial years ending March

₹ Cr	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	356	257	660	968
Profit for the year	624	551	768	722
Working capital changes	-34	-246	45	40
Direct taxes paid	-303	-154	-156	15
	-36	54	-71	-562
Fixed assets purchased	-65	-19	-28	-25
Fixed assets sold	1	53	152	1
	-346	-235	-205	-798
Interest paid	-13	-11	-8	-9
Dividends paid	-297	-183	-160	-752
Net Cash Flow	-26	75	383	-392
Free Cash Flow	291	238	632	942

Free cash flow = cash from operations − capital expenditure. Source: Yahoo Finance.

Ratios

Ratio	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROE	—	19.5%	16.2%	19.6%	17.2%
ROCE	—	25.0%	20.7%	23.6%	22.9%
Operating margin	—	29.3%	26.3%	29.9%	33.6%
Net margin	—	25.8%	25.1%	33.7%	28.7%
Debt / equity	—	0.04	0.03	0.03	0.02
Current ratio	—	3.84	5.07	6.17	6.06
Debtor days	—	23	31	31	26
Inventory days	—	174	199	214	194
Days payable	—	90	76	68	89
Cash conversion cycle	—	107	154	177	131
Working capital days	—	281	370	471	460

Computed from the reported statements: ROE on average equity; ROCE = EBIT / (total assets − current liabilities). Debtor days = receivables ÷ sales × 365; inventory and payable days use cost of goods sold; cash conversion cycle = debtor + inventory − payable days; working capital days = (current assets − current liabilities) ÷ sales × 365.

Shareholding Pattern

Numbers in percentages · as filed with NSE each quarter

Promoters 63.92%
FIIs 1.63%
DIIs 17.52%
Public 16.92%

%	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%	63.92%
	3.03%	3.33%	3.22%	3.54%	2.75%	2.18%	2.39%	2.60%	2.71%	2.81%	1.65%	1.63%
Foreign portfolio investors (Cat. I)	3.03%	3.32%	3.19%	3.40%	2.62%	2.16%	2.36%	2.54%	2.70%	2.78%	1.59%	1.58%
Foreign portfolio investors (Cat. II)			0.03%	0.14%	0.12%	0.02%	0.04%	0.06%	0.01%	0.03%	0.06%	0.05%
	15.15%	15.33%	15.84%	16.03%	16.79%	17.10%	17.23%	17.10%	17.05%	16.89%	17.80%	17.52%
Mutual funds	7.61%	7.72%	8.32%	10.43%	11.30%	11.59%	11.70%	11.74%	11.71%	11.52%	12.68%	12.83%
Insurance companies	7.52%	7.44%	7.40%	5.52%	5.39%	5.43%	5.45%	5.35%	5.30%	5.31%	5.08%	4.65%
Banks	0.02%	0.01%	0.01%	0.01%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%
Alternative investment funds		0.15%	0.10%	0.07%	0.09%	0.06%	0.06%		0.02%	0.04%	0.02%	0.02%
	17.90%	17.42%	17.01%	16.50%	16.54%	16.79%	16.45%	16.37%	16.32%	16.37%	16.63%	16.92%
Retail (up to ₹2 lakh)	12.55%	12.25%	11.98%	11.59%	11.66%	11.88%	11.56%	11.62%	11.47%	11.40%	11.58%	11.74%
HNIs (above ₹2 lakh)	0.65%	0.65%	0.57%	0.56%	0.47%	0.46%	0.46%	0.46%	0.46%	0.46%	0.46%	0.46%
NRIs	0.53%	0.54%	0.52%	0.51%	0.51%	0.53%	0.52%	0.52%	0.54%	0.54%	0.54%	0.56%
Bodies corporate	2.81%	2.77%	2.72%	2.65%	2.65%	2.67%	2.66%	2.51%	2.58%	2.71%	2.78%	2.89%
IEPF	0.88%	0.88%	0.88%	0.88%	0.93%	0.92%	0.92%	0.92%	0.96%	0.95%	0.94%	0.93%
No. of Shareholders	1,12,456	1,09,214	1,06,098	98,824	1,05,015	1,08,261	1,03,222	1,03,480	1,00,933	99,545	1,02,478	1,04,472

Source: shareholding patterns filed by the company with NSE. Public = non-institutional holders. Tap a row marked + for its breakdown.

Mutual funds & institutions holding Pfizer

Holder (above 1%)	Stake
Nippon Life India Trustee LtdMutual fund	4.11%
QUANT MUTUAL FUNDMutual fund · see the fund house	3.98%
Life Insurance Corporation Of IndiaInsurance	3.25%
ICICI PRUDENTIAL FUNDMutual fund · see the fund house	2.22%

As named in the shareholding pattern for Sep 2026 filed with NSE; mutual funds together hold 12.83% of the company. Shareholders below 1% are not named in the filing.

Documents

Announcements

All announcements on NSE →

Annual reports

Credit ratings

None filed recently.

Concalls & investor meets

Filings made by the company with NSE; documents open on NSE's website.

Key dates

Results announced: 28 Oct 2026
Ex-dividend date: 17 Jul 2026
Latest quarter: 30 Jun 2026
Financial year end: 31 Mar 2026

Trade with our broking desk

Open a trading & demat account through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539; NSE AP0153037862, BSE AP01095201177059). Execution and service only: no tips or research.

Open an account How it works

Latest news

In the news

No recent coverage found.

From the company (NSE)

Headlines from news publishers (via Google News) and the filings of the company with NSE; they open on the source website. Headlines with price targets or buy/sell calls are left out. News is for information only and is not a recommendation.

Questions about Pfizer Limited

What is the share price of Pfizer Limited today?

Pfizer Limited (PFIZER) last traded at ₹3,814.00 on NSE (16 Oct 2026, 3:30 PM IST). Prices may be delayed.

What is the market cap of Pfizer Limited?

About ₹17,448 crore at the latest price.

What is the P/E ratio of Pfizer Limited?

About 23.7 times its earnings over the last 12 months.

Is Pfizer Limited a good investment?

We do not give views on individual shares. Whether any share suits you depends on your goals, time horizon and risk appetite; for long-term goals, a diversified mutual fund is often a simpler way to own shares. Investments in securities markets are subject to market risks.

How can I buy Pfizer Limited shares?

You need a trading and demat account with a SEBI-registered stock broker. We can help you open one through Parshvanath Investments, an Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539). We provide execution and account service only, not tips or research.

Important. Prices from NSE via Yahoo Finance. Quarterly and annual results, shareholding and documents are taken from the filings the company made with NSE; balance sheet, cash flow and valuation figures are compiled by Yahoo Finance; ratios are computed by us from them. Figures may be delayed or revised. This page is for information only: it is not research, a recommendation or an offer to buy or sell any security. Investments in securities markets are subject to market risks; read all related documents carefully before investing. Plenitude Connect Private Limited is an AMFI-registered Mutual Fund Distributor (ARN-130934); share broking is offered through Parshvanath Investments, Authorised Person of Master Capital Services Ltd (SEBI Reg. INZ000210539).

Talk to us

Have a question about this topic?

Tell us a little about your situation and an expert will call you back, usually within 2 hours on business days.

Get in touch

We typically respond within 2 hours on business days.

Call us

CA Amit Kumar Jain+91 93522 44475 Arihant Jain+91 80056 49698 Poornima Jain+91 92525 44475

Email ussupport@plenitude.co.in

WhatsAppChat with an expert

Visit us5C, Laxmi Colony, Near Bohra Ji Ka Bagh, Opp. Laxmi Mandir Cinema, Tonk Road, Jaipur, Rajasthan 302015

Mon–Sat · 10:00 AM – 7:00 PM IST

In your free consultation

A health check of your current investments
A goal-based plan for retirement, education or a home
Ways to save tax that fit your situation
Clear next steps, with zero pressure to invest

2,000+Investors

₹250 Cr+Client assets

15+ yrsExperience

AMFI Registered Mutual Fund Distributor · ARN-130934

Experts are available Mon–Sat, 10 AM – 7 PM

Book your free wealth consultation

100% free
No obligation
Reply within 2 hours

First name *

Last name *

Email *

Phone *

+91

I'm interested in *

Best day for a call

Preferred time

How can we help? (optional)

Upload your portfolio (optional, get a free expert review)Attach your portfolio statement · PDF, Excel or CSV (e.g. CAS), max 10 MB

I consent to being contacted by Plenitude Connect about financial services. My data will be handled as per the Privacy Policy.

Join 2,000+ investors who plan with Plenitude

Your details are private and never shared.